{"id":"d3f2b3049a2c","type":"article","url":"https://hartvaat.nl/2026/11/10/opioidgebruik-verstoort-coronair-microcirculatie-niet-bij-anoca-registryanalyse/","title":"Opioidgebruik verstoort coronair microcirculatie niet bij ANOCA — registryanalyse","title_en":"Impact of Opioid Exposure on the Coronary Microvasculature in ANOCA: A Coronary Microvascular Disease Registry Analysis.","category":"chronische nierziekte","category_label":"Nierziekte","professions":["cardioloog"],"tags":[],"journal":"Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions","doi":"10.1002/ccd.70956","source_url":"https://doi.org/10.1002/ccd.70956","authors":["Jason Galo","Abdullah Al Qaraghuli","Kalyan R Chitturi","Sevket Ozturk","Vaishnavi Sawant","Ronald Cadillo Hernandez","Shuchi Abhishek","Nicolas Cimino","Matteo Cellamare","Cheng Zhang","Beni R Verma","Anirudh Rao","Hector M Garcia-Garcia","Ron Waksman","Hayder Hashim","Brian C Case"],"significance":4,"published":"2026-11-18","source_date":"2026-11-10","image":"","kennis":["https://hartvaat.nl/kennis/nierziekte/nierziekte-en-cardiovasculair-risico/","https://hartvaat.nl/kennis/nierziekte/contrastmiddel-en-nierfunctie/"],"congress":"","summary_en":"An analysis of 367 patients with angina and non-obstructive coronary arteries (ANOCA) found no independent association between opioid exposure and impaired coronary microvascular function. While unadjusted data showed lower microvascular resistance reserve (MRR) in opioid users, this difference disappeared after multivariable adjustment for factors like hemoglobin and chronic kidney disease. The results indicate that opioid use likely reflects a more complex clinical phenotype rather than directly impairing microvascular vasodilation.","created":"2026-11-11T02:31:32Z","updated":"2026-11-11T02:31:32Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Een analyse van 367 patiënten met angina pectoris bij niet-obstructieve coronaire arteries (ANOCA) toont aan dat langdurig opioidgebruik niet onafhankelijk correleert met een verminderde coronair microcirculatoire functie. Hoewel onverstelde analyses een lagere microvascular resistance reserve (MRR) zagen bij opioidgebruikers, verdween dit effect na correctie voor confounders zoals hemoglobine en nierfunctie. De bevindingen suggereren dat opioidexpositie eerder een marker is van een complexere klinische fenotypiek dan een directe oorzaak van microvasculaire dysfunctie.","abstract_original":"BACKGROUND: Angina with non-obstructive coronary arteries (ANOCA) accounts for up to 50% of patients undergoing angiography for chest pain, with many cases due to coronary microvascular dysfunction (CMD). Opioids are often prescribed to patients for multiple indications, and their effects on coronary microcirculation are unclear. AIMS: To investigate the association between opioid exposure and coronary microvascular dysfunction in patients with ANOCA, focusing on differences in CMD prevalence, CFR, IMR, and MRR between opioid users and non-users, and whether opioid exposure independently predicts impaired microvascular vasodilatory function. METHODS: A total of 367 ANOCA patients from the Coronary Microvascular Disease Registry (NCT05960474) who underwent invasive coronary function testing (August 2021 to March 2025) were analyzed. CMD was defined by coronary flow reserve (CFR) < 2.5 and index of microcirculatory resistance (IMR) ≥ 25; microvascular resistance reserve (MRR) < 3.0 indicated impaired vasodilatory capacity. All indices were measured by bolus thermodilution. Opioid exposure during the 12 months preceding testing was obtained from the electronic health record and Surescripts database. Patients were categorized as opioid users (≥ 1 prescription > 3 days) or non-users, and stratified as short-term (< 90 days) or long-term (≥ 90 days). The primary outcome was the comparison of CMD prevalence and physiologic parameters (CFR, IMR, MRR) between exposure groups. Because groups differed at baseline, unadjusted comparisons were descriptive; the primary interpretation used a multivariable model of log-transformed MRR adjusted for hypertension, hemoglobin, and chronic kidney disease. RESULTS: Opioid users had more hypertension, chronic kidney disease, and CCS class IV angina, and lower hemoglobin (12.38 ± 1.60 vs. 13.32 ± 1.58 g/dL; all p < 0.05). CMD prevalence was numerically higher among opioid users (19/55; 34.5%) versus non-users (85/312; 27.2%), but not significantly (p = 0.27). Mean CFR was lower in opioid users (2.84 ± 1.65 vs. 3.32 ± 1.80; p = 0.06), suggesting a trend toward impaired coronary flow. In unadjusted analysis, mean MRR was lower in opioid users (3.27 ± 1.78 vs. 4.02 ± 2.32; p = 0.01). Mean of IMR was similar between groups (18.51 ± 10.58 vs. 18.60 ± 12.24; p = 0.96). After adjustment, the MRR difference was no longer significant (β = -0.11 on the log scale, an estimated 10.5% lower MRR; 95% CI -0.30 to 0.08; p = 0.25); hemoglobin was the only independent correlate (p = 0.011). CONCLUSIONS: In ANOCA, opioid users represented a distinct clinical phenotype with greater comorbidity, lower hemoglobin, and more severe angina. Their lower unadjusted MRR did not persist after adjustment, and CMD prevalence, CFR, and IMR were similar between groups, suggesting that opioid exposure marks a more complex clinical state rather than independently impairing microvascular vasodilatory function. Residual confounding cannot be excluded, and these exploratory findings require confirmation in larger studies. TRIAL REGISTRATION: Coronary Microvascular Disease Registry, clinicaltrials.gov, NCT05960474."}